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Abstract 
Breast cancer places a large burden on many communities, causing mortalities, and 
lasting physical, mental, and financial damage. The majority of cases are not caused by a genetic 
risk factor, which speaks to the importance of addressing environmental risk factors to reduce 
disease burden. Bisphenol-A (BPA) is linked to increase risk for and metastasis of breast cancer. 
BPA is widely used in plastics, exposing a huge portion of the United States population. This 
project used the model developed for the Green Choices program to trial response to the use of 
an environmental risk survey and education tool that can be utilized in a primary care setting. 
Surveys and an education sheet on reducing BPA exposure was distributed virtually to pregnant 
women and women with children under the age of five, a population that is highly susceptible to 
the negative impacts of BPA on breast tissue. Although plastic use in participants did not show a 
statistically significant reduction, response to the information was positive. Participants agreed 
that they want more environmental health education from their providers and believed their 
behavior would change in the future. This project would benefit from clinic-based 
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Breast cancer is a pervasive issue for women around the world. Recent data from 2018, 
published by the World Cancer Research Fund (2018), found the incidence of breast cancer to be 
over 2 million. It is the number one cause of cancer in women worldwide and the second most 
common cancer overall (World Cancer Research Fund, 2018).  
Breast cancer accounts for 15.3% of all new cancer cases among women in the United 
States. On average, 12.4% of women will be diagnosed with breast cancer during their lifetime 
(National Cancer Institute, n.d.). In California, breast cancer is the most commonly diagnosed 
cancer in females, regardless of ethnicity or race. 31.8% of newly diagnosed cancers in women 
are attributed to breast cancer and 15.6% of cancer-related deaths (Killion et al., 2018). The 
American Cancer Society (2019) estimates that there will be 27,700 new cases of breast cancer 
diagnosed in California in 2019 and 4,560 deaths. 
Besides the physical toll and potential loss of life, breast cancer also greatly affects the 
psychological wellbeing of both the patient as well as her family, friends, and caregivers. Using 
data from the Women’s Health Initiative, Jones et al (2015) assessed the quality of life of women 
before and after a diagnosis of breast cancer using two sections of the Rand-36 assessment tool, 
which asks participants to numerically rate how they feel on questions about physical and 
emotional health. This study showed that when compared with pre-diagnosis levels, depressive 
symptoms increased by 20% in the first six months, while physical function and mental health 
both decreased in the first year. Many survivors live with a constant fear of relapse. Women were 
at a higher risk of having moderate to high fear of recurrence, especially if they were younger or 
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lacked social support (Koch-Gallenkamp et al., 2016). Vulnerable populations may be even more 
at risk of adverse outcomes. The Breast Cancer Care in Chicago interviews showed that African 
American and Latina breast cancer patients had higher levels of negative psychological effects 
associated with a diagnosis of breast cancer (Tejeda et al., 2017).  
Caregivers take on a tremendous job in caring for someone with cancer. A study 
published by the American Cancer Society showed that caregivers were more distressed and had 
higher levels of anxiety when compared to patients. Among those studied, 43.6% of caregivers 
reported having at least 10 unmet needs, including receiving information on healthcare services 
and emotional support (Sklenarova et al., 2015). 
In additional to the impact of the disease on the mental health of a patient, her family, and 
her caregivers, a cancer diagnosis can have a devastating financial impact. A study of cancer 
survivors using data from the 2011 Medical Expenditure Panel Survey, which included 19.6 
million participants in the United States, found that 28.7% of cancer survivors reported having 
financial burdens (Kale & Carroll, 2016). Financial burden was defined as having to borrow 
money, declare bankruptcy, worry about paying for bills or visits, or making financial sacrifices. 
This financial burden also increased depressive symptoms and concern about cancer recurrence 
(Kale & Carroll, 2016). A survey by The Pink Fund (2017), a nonprofit charity that provides 
financial assistance for breast cancer patients, found that 47% of breast cancer patients had to use 
their retirement savings to pay for treatment and 41% skipped treatment or medication due to the 
inability to pay.  
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Problem Description 
Given the devasting impact of the disease, researchers, policy makers, and advocates 
need to more closely evaluate the risk factors associated with the disease. Contrary to popular 
belief, family history and genetics do not play the strongest role in developing breast cancer. 
According to the American Cancer Society (2017), eight out of ten women who get breast cancer 
do not have a family history of breast cancer. There are many known modifiable and non-
modifiable risk factors (American Cancer Society, 2017).  
Risk Factors 
The Centers for Disease Control and Prevention (CDC) separates risk factors into two 
categories, modifiable and nonmodifiable (CDC, 2018). Nonmodifiable risk factors include age, 
genetic mutations, reproductive factors like early menstruation and menopause, breast density, 
family or personal history of breast cancer, and radiation therapy (Centers for Disease Control 
and Prevention, 2018). Genetic mutations also greatly influence an individual’s risk. It is 
estimated that women with the BRCA1 and BRCA2 gene mutations have a greatly increased risk 
of developing breast cancer, estimated at 72% and 69% (U.S. Breast Cancer Statistics, n.d.). 
Nonmodifiable factors are difficult to mitigate, but monitoring modifiable risk factors may 
reduce risk. Modifiable risk factors are: sedentary lifestyle, obesity, hormone replacement 
therapy, reproductive factors including age at first live birth, nulliparity, and breastfeeding, and 
drinking alcohol. It is estimated that 42% of all cancers and 45.1% of cancer mortalities are 
attributable to modifiable risk factors (Islami et al., 2018).  
The National Institute of Environmental Health Sciences (NIEHS), which researches the 
interaction between environmental exposures and human health, has indicated that 
BISPHENOL (BPA) AND BREAST CANCER  9 
 
environmental exposures may influence breast cancer risk; they further emphasize the need for 
more research in areas of the country with unusually high incidence rates (NIEHS, 2018). The 
World Health Organization and International Agency for Research on Cancer stated that 7-19% 
of cancer may be attributed to toxic chemical exposure in the environment (Goodson et al., 
2015). A study conducted on 85 examples of chemicals showed that 59% had low-dose effects, 
which over time or in combination with other chemicals, may contribute to cancer incidence 
(Goodson et al., 2015).  
Bisphenol-A 
 Bisphenol-A (BPA) is a largely produced chemical that is present in a wide-range of 
products. BPA is used in polycarbonate plastics, which are used in food packaging, baby bottles, 
water bottles, and medical equipment. BPA is also used to produce epoxy resins, which line food 
cans and water pipes (National Institute of Environmental Health Sciences [NIEHS], 2019). BPA 
is also found in other products, including dental fillings and receipts (Shafei et al., 2018a). BPA 
resembles an estrogen receptor agonist and can bind with estrogen receptors in the body (Shafei 
et al., 2018b). Chemicals that display this ability are classified as endocrine disrupting chemicals 
(EDCs) and have the potential to interfere with the endocrine system resulting in adverse health 
effects (NIEHS, n.d.).  
 The American public is heavily exposed to products containing BPA. The Centers for 
Disease Control and Prevention (CDC) tested 2,517 individuals ages six and above for urinary 
levels of BPA. 93% of those tested were found to have BPA in their urine (NIEHS, 2019). In a 
study of breast tissue collected from 36 mastectomies and 14 breast reduction surgeries, Low 
concentrations of BPA were found in 30.6% of the breast tissue samples (Reeves et al., 2018).  
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This raises concern over the health effects that this wide-spread exposure is contributing 
to and the lack of research supporting the safety or potential harm of the chemicals used in 
everyday products. BPA has been linked to breast and prostate cancer, precocious puberty, and 
other endocrine disorders, including obesity and polycystic ovary syndrome (Shafei et al., 
2018b), Only an estimated 10 to 11% of research projects by the National Institutes of Health 
(NIH) and the U.S. Department of Defense (DoD) have addressed environmental risk factors for 
breast cancer (NIEHS ,2013).  
The Role of Primary Care Providers 
 Even with the available data linking environmental exposures to increased health risks, 
many providers are not educating patients on their risks. There was a lack of studies into 
provider barriers to provide an insight into this issue. A survey of 191 pediatric oncologists 
showed that only 7% had received training on how to conduct an environmental health history, 
and 92% expressed the desire for more information and training regarding environmental 
exposures and cancer risk (Zachek et al., 2015). Two surveys of healthcare providers in Canada 
revealed similar results. Out of 203 primary care providers, only 18.1% reported receiving 
training in environmental health history, but 92% felt knowing about exposures was important 
(Sanborn et al., 2019).  A survey of 135 healthcare providers reported that lack of knowledge of 
and confidence in discussing exposure risk were major barriers in providing environmental 
education during reproductive health visits (Williamson et al., 2017). This project seeks to trial a 
tool that can simplify environmental health history and education to make the use easy for 
providers and patients.  
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Available Knowledge 
Literature Review Methods 
Due to a lack of studies regarding environmental health education and behavior change, 
the review of knowledge was conducted with the intention to support the development and use of 
necessity of an education tool to reduce the use of BPA exposure in primary care patients. The 
following PICO question was used to guide a literature review of existing research, In the 
general population, how does BPA exposure impact the risk for breast cancer? A literature 
review was performed using the PubMed database and the search terms ‘BPA’ and ‘breast 
cancer’. Articles were originally filtered to those published within the last 10 years for relevance, 
English language, and full-text available. This search resulted in 143 articles. An abstract screen 
was performed and articles were excluded if they were not directly studying breast cancer 
incidence and the effect of BPA on breast cancer, resulting in 59 articles. These results were then 
reduced to be within the last five years to ensure that only recent evidence was included. The 
articles were then screened, excluded if there was no explanation of methods, the study was not 
directly related to breast cancer incidence, or if no full-text was available. 19 articles were 
chosen to be included in the review of evidence, including one literature review, one study of 
human participants, and 17 experimental studies using animals or cell lines (Appendix A).  
Review of Evidence  
A literature review of the carcinogenic potential of BPA in vivo, concluded from 38 
studies that BPA can be reasonably anticipated as a human carcinogen based on animal and 
genetic findings. BPA was shown to change gene expression, which can influence cancer risk far 
beyond the immediate time of exposure (Seachrist et al., 2016). Only one study using human 
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participants was included. Female participants in the Centers for Disease Control and 
Prevention’s National Health and Nutrition Examination Survey (NHANES), provided urinary 
BPA annually from 2003-2010. Women in the study self-reported whether they were diagnosed 
with breast cancer during that time. There was no significant association found between breast 
cancer and BPA urinary levels (adjusted odds ratio [OR], 95% confidence interval [CI] 0.76, 
0.73). However, the authors discuss the need for more comprehensive research (Morgan, Deoraj, 
Felty, & Roy, 2017). The following studies review more specific influences of BPA on normal 
and malignant breast cells.  
Animal Studies. Changes in normal mammary tissue was shown in two studies using 
rats. One study using rats (n=22), sought to investigate the impact of perinatal BPA exposure in 
offspring at 22, 100, and 400 days after birth. At 0.25mg/kg, a low dose, male rats showed an 
increase in mammary development (p=0.05) and female rates showed intraductal hyperplasia 
(p=0.017) (Mandrup, Boberg, Isling, Christiansen, & Hass, 2016). A case-control study using 
female albino rats (n=30) exposed to 5mg/kg of BPA a day for 8 weeks showed hyperplasia of 
mammary epithelial cells and ducts, and increased proliferation of mammary glands (p=0.0001) 
(Ibrahim, Elbakry, & Bayomy, 2016). 
Mice were used in a study by Palacios-Arreola, (2017), to evaluate if prior BPA exposure 
affected tumor growth. Mice were injected with breast cancer cells, 4T1, to induce tumor growth. 
Those that had been exposed to one dose of 250 micrograms per kilogram of BPA at the start of 
the study had 88% larger tumors (p=0.007), and a decrease in the release of pro-inflammatory 
chemicals which would regulate tumor growth, interferon-gamma (p=0.0034) and tumor necrosis 
factor-alpha (p=0.0244) (Palacios-Arreola, Nava-Castro, Del Río-Araiza, Pérez-Sánchez, & 
Morales-Montor, 2017).  
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Cell Lines. A study using three different cells lines in vitro, including MCF-7 for breast 
cancer, exposed cells to levels of BPA commonly found in food (Hernandez-Hernandez et al., 
2019). BPA was shown to be cytotoxic to MCF-7 cells above 50mcg/mL. The authors estimated 
the average daily exposure of BPA to be above 5.7mcg/day (Hernandez-Hernandez et al., 2019). 
4-methyl-2,4-bis(4-hydroxyphenyl) pent-1-ene (MBP) is a metabolite of BPA that is formed in 
the human body which was previously shown to be a more potent influencer of estrogenic 
activity than BPA itself (Hirao-Suzuki, Takeda, Okuda, Takiguchi, & Yoshihara, 2019). When 
exposed to MBP, the MCF-7 cell line proliferated in a dose-dependent manner. MBP also caused 
downregulation of the ERα protein (Hirao-Suzuki, Takeda, Okuda, Takiguchi, & Yoshihara, 
2019).  
A study using HeLa cells demonstrated that BPA induced instability in chromosomes and 
other defects in the cells that may lead to breast cancer development (Kim, Gwon, Kim, Choi, & 
Jang, 2019). This study demonstrated that beyond being an endocrine disrupting chemical, BPA 
can act in other ways to disrupt normal cell growth.  
GPER Pathways. A study using Bovine vascular endothelial cells (BVECs) and breast 
cancer cells (SkBr-3 and MDA-MB-231) were used to evaluate the effect of BPA on G-protein 
estrogen receptors (GPER) (Xu et al., 2017). Vascular endothelial cells were studied because 
they can undergo angiogenesis, encouraging malignant cell growth. GPER may act 
independently of the more commonly known estrogen receptors, and may contribute to ER- 
breast cancer. Cells exposed to BPA were shown to have increased proliferation and migration of 
the BVECs and tumor growth in the breast cancer cell lines. BPA also triggered an increase 
vascular endothelial growth factor (VEGF), through the GPER pathway, an angiogenic cytokine 
that can be released by malignant cells to promote growth (Xu et al., 2017).  
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A study of three breast cancer cells lines, MDA-MB-231, MCF10A, and MCF12A, was 
conducted to determine the effects of BPA (Castillo Sanchez, Gomez, & Perez Salazar, 2016). 
While BPA was not found to be cytotoxic, there were changes made in the cells when exposed to 
BPA. Through GPER, 1 µM of BPA induced the migration of MDA-MB-231 cells (P<0.05). 
These findings show that low doses of BPA can induce cell changes which made lead to breast 
cancer (Castillo Sanchez, Gomez, & Perez Salazar, 2016).  
Nanomolar BPA triggered proliferation of estrogen positive (MCF-7) and negative 
(SkBr3) breast cancer cells (Song et al., 2015). Proliferation was found to occur independent of 
both ER and GPER pathways, but was increased by estrogen related receptors (ERR) (p<0.05 at 
24 hours and p<0.01 at 48 hours) (Song et al., 2015). 
Breast Cancer Subtypes. A study using estrogen-receptor negative inflammatory breast 
cancer (IBC) cells, found that cells exposed to BPA had increased epidermal growth factor 
receptor (EGFR) activation and proliferation (p<0.05), a characteristic of IBC (Sauer at al., 
2017). EGFR activation promotes tumor growth and proliferation. Treatment of IBC includes the 
use of EGFR inhibitor medications, so BPA may influence resistance to this treatment (Sauer at 
al., 2017). 
Ductal carcinoma in situ (DCIS) can lead to the development of breast cancer in 20-50% 
of those affected (Kim, Kim, Piao, & Moon, 2019). A study using estrogen-receptor negative 
(ER-), progesterone-receptor negative (PR-), and human epidermal growth factor receptor 
negative (HER2-) DCIS cells, in vitro and in vivo, using mice, were examined to evaluate the 
effect of varying doses of BPA. Cells exposed to BPA were found to have 291 genes that were 
altered in their expression. BPA promoted proliferation and migration of DCIS cells and 
macrophages which may lead to tumor growth (at 24 hours, p<0.0001, at 48 hours, p=0.0008, at 
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72 hours, p=0.0003). The in vivo cells were exposed to a similar level of BPA that is commonly 
found in drinking water, which led to an increase in tumor size (592.1 ± 87.02 mm³ vs 361.5 ± 
66.90 mm³, p=0.0619) (Kim, Kim, Piao, & Moon, 2019). 
A study of triple-negative breast cancer (TNBC) cells, using the cell lines MDA-MB-231 
and BT-549, showed that BPA influences the cells in this aggressive form of breast cancer as 
well. BPA exposure increased motility and the expression of matrix metalloproteinases (p<0.01), 
which allows for migration of the TNBC cells (Zhang, Liu, Weng, & Wang, 2016).  
Genes and Proteins. A study using immature mammary epithelial cells, MCF10A, 
showed that BPA influences the response of these cells to bone morphogenetic protein 2 (BMP2) 
and 4 (BMP4) (Clément et al., 2017). BMP2 and BMP4 are growth factors that stimulate tumor 
cell growth through signaling pathways that are found in breast cancer. Low-dose, chronic BPA 
exposure pre-activated BMP signaling through alteration of receptors (p=0.02) (Clément et al., 
2017). 
MCF7 in vitro cells and in vivo, in rats, showed a 9.4 fold increase in homeobox-
containing gene, HOXB9, expression when exposed to 100 nM BPA.  HOXB9 is involved in 
normal mammary gland development and its alteration has been linked to breast cancer, and 
tumor metastasis (Deb et al., 2016). Another homeobox-containing gene, HOXC6, has been 
found to be overexpressed in breast cancer cells. BPA increased the expression of HOXC6 in 
vitro and in vivo by over 4% (p<0.05) (Hussain et al., 2015). 
Estrogen receptor negative (ER-) breast cancer cells were studied in vitro, using SkBr3 
and MDA-MB-231 cell lines (Zhang, Wang, Liu, & Ge, 2016). ER- breast cancer is more often 
associated with a worse outcome, metastasis and relapse. BPA exposure resulted in 
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downregulation of forkhead-box protein A 1 (FOXA1), which prompts mesenchymal transition 
(EMT), allowing for cell migration (at 6 hours, p<0.05, from 12-48 hours, p<0.01). In addition to 
FOXA1, BPA exposed cells showed downregulation of one other gene and upregulation of 12 
genes that are associated with breast cancer (Zhang, Wang, Liu, & Ge, 2016).  
BPA Alternatives. In one case-control study, MCF-7 breast cancer cells were exposed to 
BPA, and the alternatives that have been developed, bisphenol-S (BPS) and bisphenol-F (BPF) 
(Kim at al. (Choi), 2017). The control, estradiol, and BPA, BPS, and BPF increased proliferation 
of the MCF-7 cells. Cells exposed to BPA, BPS, and BPF showed increased migration (P<0.05), 
and also changes in gene expression (P<0.05) (Kim at al. (Choi), 2017).  This study shows that 
alternative products related to BPA may function in a similar fashion and increase the risk for 
breast cancer.   
Rationale 
The Health Belief Model (HBM) (Appendix B) guided the development of this project. 
The HBM explains how a person’s perception of an illness and their belief in an intervention 
influences their health behavior (LaMorte, W, 2019). The model is based on six constructs: 
perceived susceptibility, perceived severity, perceived benefits, perceived barriers, cue to action, 
and self-efficacy. Perceived susceptibility is the individual’s belief of their personal risk for 
illness and perceived severity is their belief of the seriousness of the illness. Perceived benefits 
are the personal beliefs of how the suggested action will positively impact the individual’s risk 
for illness. Perceived barriers are the individual’s beliefs about what stands in their way of 
implementing the suggested action or change. The cue to action is the prompt to the individual to 
initiate change and self-efficacy is the individual’s confidence in their behavior (LaMorte, W, 
2019).  
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In relation to the proposed project, a patient will consider their own potential 
susceptibility to breast cancer when considering their exposure to BPA, the benefits of 
implementing the changes suggested in the education sheet, and their own barriers to making the 
changes. The education sheet will act as the cue to action to encourage participants to initiate 
change in their lives. Considering these constructs allows for the development of a pertinent 
education tool that encourages behavior changes that are attainable for the population. 
Specific Aims 
The AIM statement created to guide this quality improvement project is, by May 2020, a 
survey of BPA exposure and education sheet with included tips for reducing exposure will be 
utilized to influence behavior change, with a goal of 20 individuals participating. By July 2020, a 
brief education module detailing the intervention and outcomes will be administered to current 
and recent graduates of the University of San Francisco DNP program and a provider from 
Native American Health Center. The target population is pregnant women and mothers with 
children under the age of five. This aim statement was accomplished through the completion of 
the following goals. The project was completed in July 2020.  
1) A pre-survey will be used to assess the patient’s current knowledge of BPA, their risk 
for exposure, and desire for environmental health education. 
2) An education sheet will be provided that includes a brief description of the influence 
of BPA exposure on health risks and simple tips to avoid exposure in daily life. 
3) A post-survey will be used to measure knowledge attainment, desire to implement 
behavior changes, and likelihood of recommending behavior change to others. 
BISPHENOL (BPA) AND BREAST CANCER  18 
 
4) A short education module will be developed and distributed to fellow primary care 
providers and DNP students to introduce environmental risk assessment and 




The setting and stakeholders of this project have been impacted by the COVID-19 
pandemic. The original setting used to assess need and chosen for implementation was a 
federally qualified health center in Oakland, CA named Native American Health Center 
(NAHC). The gap analysis and SWOT analysis were performed based on the current practices 
and patient population at NAHC. To adjust to the social distancing and shelter in place orders, a 
virtual platform was utilized to distribute the surveys and education tool. The stakeholders of this 
project were then adjusted to be this DNP student, the chair and co-chair of the project 
committee, and the primary care provider representing NAHC.  
Intervention  
Gap Analysis  
 A gap analysis (Appendix C) revealed that the current practice at NAHC does not include 
a tool or standard practice for assessing environmental risk. With short primary care 
appointments, providers may find it challenging to provide thorough preventative care or provide 
concise, usable information about exposures. The desired state of practice would allow providers 
access to a tool that is well-received by patients and easy to implement. The plan for this project 
is to trial a simple, quick, and effective environmental risk assessment and education tool.  
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SWOT Analysis 
 A SWOT (strengths, weaknesses, opportunities, threats) analysis was conducted for this 
project (Appendix D). An important strength is first and foremost determining if there is interest 
in this kind of information in the primary care setting. The survey was designed to provide 
results that support the need and demand for implementing environmental health education into 
standard preventative care. Other strengths include providing the information to the target 
population and increasing the quality of care. This project provides the opportunity to increase 
communication about environmental risk factors and the need for action to prevent negative 
health outcomes due to exposure. The information is provided in a community setting, so there is 
opportunity for greater dissemination through participants telling their family and friends. 
Weaknesses include implementation in the virtual setting related to COVID-19 restrictions, data 
that is reliant on self-reporting, and the time constraints of short primary care appointments. It 
can be difficult to provide thorough education and assessment during an appointment with a very 
limited time period, when there may be more acute issues to address. Threats to the success of 
the project include the populations’ perceived susceptibility to exposures and disease, and the 
availability of resources to the target population to implement desired change. There is also the 
threat of perceived importance by providers who may not prioritize exposure risk during visits.  
Purpose and Processes 
 To address the need for the reduction of environmental exposures, elements of the Green 
Choices program developed by Planned Parenthood and the Rethink Plastic pilot study were 
utilized. The Green Choices program was developed to address increasing rates of reproductive 
cancers and decreasing fertility rates (Worthington, Armstrong, & Debevec, 2010). The surveys 
and education sheets were developed by an advisory committee comprised of environmental and 
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reproductive health experts to address the most common exposures. The included exposures 
were: plastics, personal care products, fruits and vegetables, fish, lead, pesticides, cleaning 
products, and tobacco smoke. The material was written to be at a 6th grade reading level, based 
on the recommendation of a literacy expert (Worthington, Armstrong, & Debevec, 2010). 
 The Rethink Plastic Pilot study was conducted by Plastic Pollution Coalition, Child 
Health and Development Studies, and California’s Breast Cancer Research Fund to evaluate if 
education could impact behavior change and decrease estrogenic activity in the body (Curtis, 
2018). This study provided participants with an education session about the dangers of exposure 
to plastics and BPA, and tips to reduce their daily exposure. The results showed that participants 
successfully decreased their use of plastics, shared the information with family and friends, and 
had a decrease in estrogenic activity (Curtis, 2018).  
 The target population of pregnant women and women with children under 5 years of age 
was selected based on the theory that exposures pose a greater risk during certain periods of 
susceptibility. When discussing breast cancer risk, pregnancy is identified as a period of 
susceptibility for the mother due to growth and changes in breast tissue, and for the fetus, 
especially during the embryonic stage when breast tissue is developing (Terry et al., 2019). The 
World Health Organization (2011), stated that the impact of environmental exposures may be 
greater in early life due to the rapid growth of children during this time period. The effects of 
early exposure may also negatively impact health and developmental later in life (World Health 
Organization, 2011).  
 The initial portion of the project included a pre-survey to assess interest and risk of 
exposure, an education tool introducing the health risks of BPA and how to reduce exposure, and 
a post-survey that assessed behavior change and knowledge attainment. The pre-survey 
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(Appendix E) included five questions to assess plastic exposure that were used in the Green 
Choices program. Additional questions were included to gauge interest and assess if the 
population had received education on environmental risks from their primary care provider prior 
to this intervention. Participants then read the Green Choices handout on plastics and an 
education sheet on the health risks associated with BPA exposure (Appendix F). The education 
sheet encourages participants to think of their susceptibility, the severity of this exposure, and 
acts as a cue to action for a positive change. After two weeks, the participants were sent a post-
survey with the same Green Choices questions to evaluate behavior change, in addition to 
questions about knowledge attainment and dissemination (Appendix G). Demographic questions 
were included in the follow-up survey to provide anonymity. Free text spaces were available for 
participants to add feedback that cannot be expressed through the survey questions. The Green 
Choices education sheets about the remaining exposures covered by the program were included 
in the follow-up email to provide additional information and allow for broader dissemination.  
 After results were collected, a brief training module was developed for providers, 
including current or recently graduated DNP students. This module presented results from the 
pilot survey, provided the resources used, and explained ideas for implementation in a primary 
care clinic in a PowerPoint presentation that was sent through email. The module was shared 
with the primary care provider, and nurse practitioner preceptor, from NAHC who then 
disseminated it within the organization. 
Implementation 
 The components of the development, implementation, and analysis plan are demonstrated 
in the work breakdown structure (Appendix H). This breakdown of tasks was used to detail the 
schedule in the included GANTT chart (Appendix I). The plan for this project was changed and 
BISPHENOL (BPA) AND BREAST CANCER  22 
 
redeveloped due to the COVID-19 pandemic and shelter in place order. The planning and 
development phase started early in April 2020. The surveys and education sheet were completed 
April 6, 2020 and approved by the project chair and co-chair on April 8, 2020. The 
implementation phase began April 10, 2020 with the distribution of pre-surveys and the plastics 
information sheet. Post-surveys were distributed on April 28, 2020. Results were analyzed in 
May 2020 and presented to providers in an education module, distributed in July 2020.  
 Through the development, implementation, and analysis of this project, communication 
was maintained between the DNP project lead, chair and co-chair. This is detailed in the 
communication matrix (Appendix J). Communication consisted of virtual communication, to 
ensure social distancing. Zoom, phone calls, and email will be utilized to maintain open 
communication and allow for feedback from the chair and co-chair. The nurse practitioner 
preceptor from Native American Health Center was utilized and involved in the dissemination of 
the education module to primary care providers.  
 The budget (Appendix K) was based on time spent with development and potential 
training for staff. The approximate starting hourly pay for a nurse practitioner at Native 
American Health Center is $48/hr. The development of the education tool and survey took about 
20 hours, totaling $960 cost. This project was conducted virtually, so there is no cost for 
materials. If this was being implemented in the clinic as originally planned, there would be 
additional cost for printing materials and training a medical assistant to assist with 
implementation. This means the total project cost was estimated as $960.  
 The return on investment varies based on the wide range of health effects attributed to 
BPA exposure. In a report by MD Anderson, the average treatment for breast cancer cost patients 
$2,727 and the average cost to insurance was $82,260, but varies as much $20,354. This huge 
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burden on patients and health care systems justifies the implementation of a simple tool that may 
decrease this burden.  
Outcome Measures 
 The outcome for both the education tool with the general population and the education 
module for providers was conducted through online surveys. The general population received a 
pre- and post-survey, while providers completed a post-survey. There were a few main goals for 
each target group that were achieved through the use of surveys. The general population surveys 
measured risk for exposure in everyday life, the desire for environmental health education, and 
behavior change after the intervention. The risk assessment questions were developed by 
Planned Parenthood, and were included in the post-survey to measure behavior change. The 
provider surveys will measure attitudes towards environmental exposure risk assessment and 
education and knowledge attainment. Providers will also be provided a space to discuss potential 
barriers to implementing environmental health risk assessment and education in their practice.  
Analysis 
 Surveys were administered using Survey Monkey. Survey Monkey provides statistical 
overview of results, and tools for data analysis, including confidence interval and statistical 
significance (Survey Monkey, n.d.). Answers were assigned a numerical value for analysis, with 
regularly being a 3, sometimes a 2, and never a 1. Results were then exported to an Excel 
spreadsheet to perform a statistical analysis. Analysis included mean values from the pre- and 
post-survey questions, and standard deviations.  A Kolmogorov-Smirnov test was performed, 
p<0.0001, which determined the sample population does not follow a normal distribution. Based 
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on the departure from normality and unpaired survey results, the non-parametric Mann-Whitney 
U test was performed to determine statistical significance with α=0.05.  
Ethical Considerations 
 This project is designed to be in line with the Jesuit values that are held by the University 
of San Francisco. Cura personalis is the Jesuit value meaning the care of the whole person 
(University of San Francisco, n.d.). Environmental risk assessment demonstrates caring for the 
physical aspect of an individual, while providing flexible tips for lowering exposure cares for 
ones’ autonomy and intellect. The project is developed to educate, and lead participants towards 
healthy choices. It does not penalize actions or designate one choice as ‘bad’. To care for the 
whole person is to respect their whole being.  
 The American Nurses Association developed a Code of Ethics to guide nursing care. The 
Code is comprised of nine provisions (American Nurses Association, 2015). While all of the 
provisions guide this project, provision two and three were especially impactful. Provision two 
states that the primary commitment of a nurse is to the patient, or population (American Nurses 
Association, 2015). Introducing environmental risk assessment and education into primary care 
shows a commitment to increasing the quality of preventative care and decreasing the health 
risks in the patient population. Provision three states that the “nurse promotes, advocates for, and 
protects the rights, health, and safety of the patient”. (American Nurses Association, 2015, p.v.). 
Environmental health involves a great deal of advocacy for safer products and more choices. The 
goal is to protect the health and safety of the general population, especially from exposures they 
may not realize are risks to their health.  
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 This project has been approved as a quality-improvement project and does not need IRB 
approval for research (Appendix L). In the development of this project, participant privacy was 
respected by using anonymous surveys. This encourages truthful responses and protects results 
from being identified. The education sheet is written in a way that makes the tips accessible for 
those of varying socio-economic levels and is written at a 6th grade reading level to ensure all 
participants can understand the information.  
Results 
Population 
 Due to limitations caused by the COVID-19, this project was implemented virtually. 
Family and friends who fell into the target population of pregnant women and women with 
children under the age of five were emailed the surveys and education sheet. Participants were 
encouraged to share the information. The pre-survey was completed by 24 participants, three of 
which identified as pregnant and 21 as having a child or children under the age of five. 
Demographics were obtained in the post-survey to ensure anonymity, which was completed by 
21 participants (Appendix M). The majority of participants identified as White, 20 of 21, and one 
identified as Asian. The most common living community was suburban, as identified by 14 
participants. Followed by six participants living in an urban environment and one in a rural 
community. Ten participants identified their annual household income as between $100,000 and 
$150,000, seven participants had an annual household income of above $150,000, and the 
remaining four participants had an income between $50,000 and $100,000.  
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Participant Surveys 
 Interest in learning about risks to personal health in their environment was expressed by 
100% of participants in the pre-survey. When asked if a healthcare provider had previously 
provided them with education about environmental health risks, 70.83% of participants indicated 
they had never received information. The majority of participants, 85.71%, indicated they would 
like their provider to provide more environmental health education during their own or their 
children’s primary care visits. The majority of participants also indicated that this education 
handout increased their knowledge of plastics and how to reduce exposure, 95.24%, and that 
they felt their behavior would change if they were provided more information, 85.71%.  One 
participant commented that it would be helpful to them in the future to have more information 
presented in a similar way as the handout, indicating it was an easy and quick reference for better 
choices. Three participants shared this information with friends or family, totaling 14 additional 
contacts. Both surveys took an average of one minute to complete.  
 Table 1 includes the mean of the answers from both the pre- and post-surveys and 
standard deviations. The post-intervention surveys showed a slight decrease in mean. Although, 
the p-values from the Mann-Whitney U test do not show a statistically significant change, this 
may be a result of the small sample size. Results from both the pre- and post-surveys are 
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Provider Survey 
 The provider survey was completed by two primary care providers, one recent DNP 
graduate, and three current DNP students. This survey was conducted to measure the response of 
providers to the environmental risk assessment tool and education sheet. Three participants 
indicated they had previously received training on assessing environmental health risks, while 
two had never received training, and one neither agreed or disagreed. Four of the six providers 
had never received training on educating patients on environmental health. Five of the current 
and future providers included in the study indicated that they would implement Green Choices or 
a similar program in their practice, and 100% agreed that the information would be beneficial for 
the populations they care for. When asked about potential barriers in implementation, two 
participants said they did not see any barriers to implementation, while the remaining 
participants identified staff availability, time, training, motivation or personal health beliefs, and 
ability of patients to access resources. See Appendix  
Discussion 
Summary 
 The goal for this project was to identify a quick and efficient tool for assessing 
environmental risks to primary care patients and provide them with education for risk reduction. 
A total of 24 participants that were either pregnant or have children under the age of 5 completed 
the pre-survey and read the education sheet. A total of 21 of the original 24 participants 
completed the post-survey. Using the results, one primary care provider and three DNP students 
were educated on the use of the Green Choices tool and possible implementation in a primary 
care clinic setting. The aim statement was completed, along with the four identified goals. The 
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response sent to the survey population was robust, obtaining more than the identified goal of 20 
participants.   
Interpretation 
 The surveyed population expressed overwhelming interest in receiving environmental 
health education in their own or their children’s primary care visits. The survey completion time 
was an average of one minute which makes this a plausible survey tool for a primary care clinic. 
The survey could be administered to the patient by the medical assistant, and given the 
appropriate education sheets. The provider would be able to briefly review the education and 
reinforce the potential risks to their health. Survey participants responded positively to the 
provided education and believed they would change their behavior if they had more information 
on their risk factors. This infers that an assessment tool and education sheet is an effective cue to 
action for the population, encouraging participants to consider their susceptibility, the benefits of 
changing their behavior, and the severity of consequences. In the context of BPA exposure, the 
education sheet provided a simple scale to identify plastics with a higher risk for BPA exposure 
and simple suggestions to reduce use. The primary care providers for NAHC did not identify any 
barriers to implementation and agreed that this information would benefit their patient 
population, although there was concern over accessibility of alternatives for a low-income 
patient population.  
Although the survey did not show a statistically significant change in behavior, there 
were many barriers to participants being able to implement change. These are mainly related to 
the shelter-in-place orders due to the COVID-19 pandemic, and may include lack of access to 
new food storage containers, and inability to frequent grocery stores resulting in continued 
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canned food use. This project should be continued with a larger population in a clinic to continue 
to evaluate effectiveness and interest.   
Limitations 
 The COVID-19 pandemic has created limitations in this project. The implementation is 
now virtual, and relies on the DNP project lead’s social and professional network. This decreases 
the variety of demographics and socio-economic levels that can be surveyed. It can also lead to 
bias in answers from participants due to personal relationships. Unfortunately, with the current 
pandemic state and shelter in place orders, these limitations cannot be mitigated. However, 
results can still be used as a basis to continue this project in person when possible and encourage 
providers to create ways to implement this screening and education.  
 A major limitation in the implementation was the lack of response by providers. Only one 
current primary care provider from NAHC has responded. While the surveyed DNP students and 
primary care provider responded positively to the presentation, the dissemination of material was 
limited. Possible reasons for this include provider burden from the COVID-19 pandemic and 
lack of presence of this DNP student in the clinic.  
Conclusions 
 This pilot project gauged interest in environmental health education in mothers and 
pregnant women. This population can be especially susceptible to toxic exposures due to periods 
of rapid growth and development. This project will serve as a basis to encourage a standard 
practice of environmental risk assessment and education during primary care visits. In the short-
term, survey results showed the desire of the target population to receive this information from 
their providers and introduced a helpful tool to providers. The population surveyed believed this 
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information could impact their behavior, improving prevention of chronic disease. Research has 
shown that BPA is associated with a large range of health conditions, including breast cancer and 
childhood obesity. In the long-term, implementing a similar module in clinics can improve 
preventative care and patient health. It will also increase patient knowledge and encourage them 
to be aware of environmental health hazards. This project has the potential to be carried out in a 
clinic by another DNP student or a provider who may want to be a champion of environmental 
health. Through education, this population can begin to make changes to benefit their health.  
 
Funding 
 The DNP project manager received two scholarships that contributed to tuition costs and 
aided indirectly in the completion of this project. Jonas Philanthropies provided one scholarship 
for promoting environmental health and doctoral education for nurses. The other scholarship was 
the Health Resources and Services Administration (HRSA) ANEW award for working with 
underserved populations at the Native American Health Center, the intended population for this 
project prior to COVID-19.  
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Appendix B 









Desired State Current State Plan of Action 
The desired state of practice 
is to include environmental 
risk assessment and education 
in primary care to decrease  
the burden of disease and 
provide a higher quality of 
preventive care.  
The current state of practice 
does not include 
environmental risk 
assessment to everyday 
exposures, outside of 
allergies, or education.  
The plan of action is to 
modify the Green Choices 
tool developed by Planned 
Parenthood to focus on 
assessing and reducing the 
risk of BPA exposure in 
mothers and pregnant 
women. The survey and 
education sheet will be 
distributed virtually, with the 
goal of being a quick and 
effective intervention.  The 
tips included will reduce the 
exposure of BPA in patients, 
therefore lowering the long-
term burden of health effects, 
including breast cancer and 
childhood obesity.  
 
  





➢ Demonstrates interest in 
environmental health 
➢ Provides usable information about 
BPA that affects the population 
➢ Provides simple tips to reduce 
exposure 
➢ Increases quality of preventive care by 
addressing environmental risks  
➢ Information needs to be provided in a 
very short window of time (2-3 
minutes) 
➢ Will not provide data on physiologic 
changes in patients and family 
members 
➢ Data collected virtually and based on 
self-report 
Opportunities  Threats 
➢ Increased communication about 
environmental risk factors in the 
community 
➢ Improved awareness of the need for 
safe products  
➢ Perceived importance of 
environmental health 
➢ Personal beliefs of patients of their 
susceptibility to disease 
➢ Availability of resources (ex. ability to 
obtain glass containers) based on 
socioeconomic status of patients  
 
  




1. I am 
a. Pregnant 
b. Have a child/children under the age of 5 
2. I am interested in learning about health risks in my environment 
a. Agree 
b. Disagree 
3. I have previously received information from my provider about my environmental 
health risks 
a. Agree 
b. Disagree  








6. I (or my family) drink from plastic bottles or cups 
a. Regularly 
b. Sometimes 
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c. Never 








9. My email for a follow-up survey in two weeks is: __________ 
  









1. The handout increased my knowledge of plastics and how to reduce my exposure 
to BPA 
a. Strongly Agree 
b. Agree 
c. Neither agree nor disagree 
d. Disagree 
e. Strongly Disagree 
f. Additional comments: ____________ 
2. I would like my provider to include more environmental health education into my 
(or my child’s) primary care visits  
a. Strongly Agree 
b. Agree 
c. Neither agree nor disagree 
d. Disagree 
e. Strongly Disagree 
f. Additional comments: ____________ 
3. My behavior would change if I was provided more information about health risks 
in my environment 
a. Strongly Agree 
b. Agree 
c. Neither agree nor disagree 
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d. Disagree 
e. Strongly Disagree 
f. Additional comments: ____________ 
4. I shared this information with friends or family 
a. Agree 
b. Disagree 
c. If so, how many: _____________ 
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10. The community I live in is: 
a. Rural 
b. Suburban  
c. Urban 
d. Prefer not to answer 
11. My identified race is: 
a. White 
b. Black or African American 
c. American Indian or Alaska Native 
d. Asian 
e. Native Hawaiian or Other Pacific Islander 
f. Other 
g. Prefer not to answer 
12. My annual household income is 
a. Under $50,000 
b. Between $50,000 and $100,000 
c. Between $100,000 and $150,000 
d. $150,000 and above  
e. Prefer not to answer 
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Appendix H 
Work Breakdown Structure 
 
  
















Weekly until project 
implementation 
Email, phone calls DNP project leader, 




progress assessment  
Monthly  Email, Zoom, phone 
calls 
DNP project leader, 
DNP chair and co-
chair, NP preceptor 
DNP data analysis Monthly Email, phone calls DNP project leader, 




Weekly as needed 
until completion 
Email, phone calls, 
Zoom meeting 
DNP project leader, 









Development of education tool and surveys $960 ($48 hourly x 20 hours) 
Distribution of materials 0$ 
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Appendix L 
Statement of Determination 
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Appendix O 
Provider Survey Results 
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